Therefore, with our current understanding of AIH disease, it is likely that the most appropriate immediate targets for AIH-2 are CYP2D6, FTCD and for AIH-1 SLA/LP/tRNP(Ser)Sec. The gene discussed is CYP2D6; the disease is autoimmune hepatitis.